Back to today’s briefing

Story perspectives

George Tidmarsh Appointed FDA Drug Evaluation Director

7/21/2025

50 12

Summary

Story summary

George Tidmarsh has been named the new director of the FDA's Center for Drug Evaluation and Research. A seasoned biotech leader and Stanford adjunct professor, Tidmarsh brings a wealth of experience, having developed multiple approved drugs. His appointment comes at a crucial time as the FDA navigates evolving regulations to enhance drug safety and tackle pressing public health issues.

History

Historical Context

The Prescription Drug User Fee Act, enacted in 1992, allowed the FDA to collect fees from pharmaceutical companies, leading to a 50% increase in drug approvals by 1996. This legislation emerged from growing public demand for faster access to medications, reflecting a broader trend in regulatory reform. George Tidmarsh's recent appointment as director highlights ongoing efforts to adapt drug safety standards to modern healthcare challenges.

1 of 2

Story summary

George Tidmarsh has been named the new director of the FDA's Center for Drug Evaluation and Research. A seasoned biotech leader and Stanford adjunct professor, Tidmarsh brings a wealth of experience, having developed multiple approved drugs. His appointment comes at a crucial time as the FDA navigates evolving regulations to enhance drug safety and tackle pressing public health issues.

1 / 2